ENOVIS CORPORATION COMMON STOCK

Enovis™ Releases AltiVate Reverse® Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse®

12 Jul 2024 08:00:00 By Nasdaq GlobeNewswire

Enovis to Participate in Upcoming Investor Conferences

10 May 2024 06:00:00 By Nasdaq GlobeNewswire

Enovis Announces First Quarter 2024 Results

02 May 2024 06:00:00 By Nasdaq GlobeNewswire

Enovis to Host First Quarter 2024 Results Conference Call on May 2nd

17 Apr 2024 07:00:00 By Nasdaq GlobeNewswire

Enovis to Participate in the 23rd Annual Needham Virtual Healthcare Conference

28 Mar 2024 07:00:00 By Nasdaq GlobeNewswire

Enovis Announces Fourth Quarter and Full Year 2023 Results

22 Feb 2024 06:00:00 By Nasdaq GlobeNewswire

Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting

12 Feb 2024 11:30:00 By Nasdaq GlobeNewswire

Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024

07 Feb 2024 16:15:00 By Nasdaq GlobeNewswire

Enovis Showcases New Foot & Ankle Offerings at the ACFAS Annual Meeting

29 Jan 2024 08:00:00 By Nasdaq GlobeNewswire

Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd

26 Jan 2024 06:00:00 By Nasdaq GlobeNewswire

Enovis Introduces the DonJoy ROAM™ OA Knee Brace

25 Jan 2024 08:30:00 By Nasdaq GlobeNewswire

Enovis Completes Acquisition of LimaCorporate S.p.A

03 Jan 2024 06:00:00 By Nasdaq GlobeNewswire

Enovis to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

28 Dec 2023 05:00:00 By Nasdaq GlobeNewswire

Enovis Announces Business Segment Leadership Transition Plan

05 Dec 2023 06:00:00 By Nasdaq GlobeNewswire

Enovis to participate in the 6th Annual EverCore ISI HealthCONx Conference

16 Nov 2023 16:15:00 By Nasdaq GlobeNewswire

Enovis Announces Third Quarter 2023 Results and Raises Full-Year Outlook

07 Nov 2023 06:00:00 By Nasdaq GlobeNewswire

Enovis™ to Showcase New Surgical Innovations at AAHKS Annual Meeting

30 Oct 2023 08:00:00 By Nasdaq GlobeNewswire

ENOVIS CORPORATION ANNOUNCES PRICING OF PRIVATE OFFERING OF $400 MILLION OF 3.875% CONVERTIBLE SENIOR NOTES DUE 2028

20 Oct 2023 06:00:00 By Nasdaq GlobeNewswire

Enovis Corporation Releases Preliminary Information About Its Performance for the Third Quarter 2023

19 Oct 2023 06:58:47 By Nasdaq GlobeNewswire

Enovis Corporation Announces Proposed Private Offering of $400 Million of Convertible Senior Notes

19 Oct 2023 06:51:48 By Nasdaq GlobeNewswire